McAdam LLC’s Alkermes ALKS Stock Holding History

McAdam LLC’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	–	–	77
2018 Q3	$0	Hold	2	–	–	﹤0.01%	657
2018 Q2	$0	Hold	2	–	–	﹤0.01%	632
2018 Q1	$0	Buy	+2	New	+$117	﹤0.01%	762

Other funds holding ALKS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

McAdam LLC's ALKS Position: Q4 2018 in Review

McAdam LLC sold out of Alkermes (ALKS) in Q4 2018, closing a stake of 2 shares.

McAdam LLC first reported a position in ALKS in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 237 funds tracked by Wall St. Rank hold ALKS as of Q4 2018.

McAdam LLC reported no remaining Alkermes position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 2 Alkermes shares in Q4 2018.
McAdam LLC first reported a position in Alkermes in Q1 2018 and held it in 3 quarters.
McAdam LLC's Alkermes position peaked at $0 in Q3 2018.
237 funds tracked by Wall St. Rank held Alkermes as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.